Forecast & RatingOnly 1 analyst currently covers Alaunos Therapeutics (TCRT.US), with a price target of $205.50 and a rating of "Hold". The sample is very small, so treat this as a reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Feb 15, 2024Price forecast
$205.5017024.99%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 14, 2023
Forecast met15.1%
Stock price$18.51
Avg. target$521.1
High target$1,125
Low target$205
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.